Oral Anticoagulants in Cancer Patients: Mixed-Results and a Lesson about Trial Enrichment

Oral Anticoagulants in Cancer Patients: Mixed-Results and a Lesson about Trial Enrichment

Two studies in the New England Journal of Medicine came to differing conclusions about the utility of oral anticoagulants in patients with cancer. This might be because they enrolled the wrong patients.

Read More